| D007700 |
Kinetics |
The rate dynamics in chemical or physical systems. |
|
|
| D008954 |
Models, Biological |
Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. |
Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic |
|
| D009829 |
Oleic Acids |
A group of fatty acids that contain 18 carbon atoms and a double bond at the omega 9 carbon. |
Octadecenoic Acids,Acids, Octadecenoic,Acids, Oleic |
|
| D010169 |
Palmitic Acids |
A group of 16-carbon fatty acids that contain no double bonds. |
Acids, Palmitic |
|
| D011193 |
Potassium Iodide |
An inorganic compound that is used as a source of iodine in thyrotoxic crisis and in the preparation of thyrotoxic patients for thyroidectomy. (From Dorland, 27th ed) |
Antistrumin,Ioduro Potasico Rovi,Iosat,Jod beta,Jodetten Henning,Jodgamma,Jodid,Jodid Hexal,Jodid Verla,Jodid dura,Jodid-ratiopharm,Mono-Jod,Pima,SSKI,Thyro-Block,Thyroprotect,Iodide, Potassium,Jodid ratiopharm,Mono Jod,Thyro Block |
|
| D011485 |
Protein Binding |
The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. |
Plasma Protein Binding Capacity,Binding, Protein |
|
| D002994 |
Clofibrate |
A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) |
Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl |
|
| D004364 |
Pharmaceutical Preparations |
Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. |
Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical |
|
| D005230 |
Fatty Acids, Nonesterified |
FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. |
Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids |
|
| D006218 |
Halofenate |
An antihyperlipoproteinemic agent and uricosuric agent. |
MK-185,MK 185,MK185 |
|